文献速递中枢神经肿瘤放疗放疗物理与技术

术前与术后分次立体定向放疗:534个切除转移瘤的单中心分析

Preoperative Versus Postoperative Fractionated Stereotactic Radiation Therapy: A Single-Institution Analysis of 534 Resected Metastases.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-08-16

单中心队列研究纳入458例患者共534个切除脑转移瘤,比较术前与术后分次立体定向放疗(FSRT)的复合终点(局部失败、结节性脑膜病、≥2级放射性坏死)。术前FSRT主要因结节性脑膜病发生率较低而优于术后FSRT。

要点

  • 术前FSRT优势主要源于结节性脑膜病发生率较低。

核心结论

  • 术前FSRT与术后FSRT相比具有优势,主要因结节性脑膜病发生率较低。
  • 术前与术后FSRT在症状性放射性坏死或局部失败终点上的差异相对较小。
  • 术前FSRT尚需前瞻性验证。

研究设计与样本

  • 单中心队列研究,纳入接受手术切除并对至少一个脑转移瘤行FSRT的患者。
  • FSRT剂量为27 Gy分3次或30 Gy分5次,可术前或术后给予。
  • 共分析458例患者的534个切除脑转移瘤,术前组235个、术后组299个。
  • 主要终点为复合终点:局部失败、结节性脑膜病和/或≥2级(症状性)放射性坏死。

主要发现

  • 术前与术后FSRT的3年复合终点分别为15%(95%CI 10%-20%)与20%(95%CI 15%-25%)。

临床怎么用

  • 对于接受手术的大或症状性脑转移瘤患者,可考虑术前FSRT以降低结节性脑膜病风险。
  • 术前与术后FSRT在症状性放射性坏死或局部失败上的差异相对较小。
  • 术前FSRT的获益需前瞻性研究进一步验证后再广泛推广。

局限性

  • 本研究为单中心回顾性队列分析。
  • 术前FSRT的获益尚需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Patients with large or symptomatic brain metastases typically have surgery followed by postoperative (post-op) stereotactic radiosurgery. However, post-op stereotactic radiosurgery leads to elevated rates of radiation necrosis (RN), nodular meningeal disease (nMD), and local failure (LF) when compared with whole brain radiation therapy. Fractionated stereotactic radiation therapy (FSRT) can deliver a higher biological effective dose and may reduce the risk of LF, and preoperative (pre-op) treatments may reduce the risk of RN and nMD through treating smaller volumes and tumor sterilization. METHODS AND MATERIALS: This single institution cohort study included patients who had surgical resection and FSRT to at least one brain metastasis. Pre-op or post-op FSRT was delivered with a dose of 27 Gy in 3 fractions or 30 Gy in 5 fractions. The primary endpoint was a composite endpoint defined by (1) LF, (2) nMD, and/or (3) grade 2 or higher (symptomatic) RN. RESULTS: Of the 534 resected brain metastases from 458 patients were eligible for analysis, 235 and 299 metastases received pre-op and post-op FSRT, respectively. Notably, 4 (1.7%) pre-op and 14 (4.7%) post-op metastases were diagnosed with nMD (P = .088). Notably, 28 (12%) and 59 (20%) metastases that received pre-op and post-op FSRT, respectively, experienced the composite endpoint (P = .018). The 3-year composite endpoint for pre-op and post-op FSRT was 15% (95% CI, 10%-20%) and 20% (95% CI, 15%-25%), respectively. CONCLUSIONS: In our study, pre-op FSRT compares favorably to post-op FSRT primarily because of a lower incidence of nMD. Differences between treatment groups for symptomatic RN or LF endpoints were comparatively smaller. Prospective validation of pre-op FSRT is needed.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Perlow HK, Hennings S, Bradshaw J, et al. Preoperative Versus Postoperative Fractionated Stereotactic Radiation Therapy: A Single-Institution Analysis of 534 Resected Metastases. Int J Radiat Oncol Biol Phys. 2025. PMID: 40825402. doi:10.1016/j.ijrobp.2025.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。